SV2010003728A - Uso de una molecula radiomarcada que se une especificamente a la ed-b de la fibronectina en un metodo para el linfoma de hodgkin - Google Patents

Uso de una molecula radiomarcada que se une especificamente a la ed-b de la fibronectina en un metodo para el linfoma de hodgkin

Info

Publication number
SV2010003728A
SV2010003728A SV2010003728A SV2010003728A SV2010003728A SV 2010003728 A SV2010003728 A SV 2010003728A SV 2010003728 A SV2010003728 A SV 2010003728A SV 2010003728 A SV2010003728 A SV 2010003728A SV 2010003728 A SV2010003728 A SV 2010003728A
Authority
SV
El Salvador
Prior art keywords
hodgkin lymphoma
radiomarced
fibronectine
molecula
specifically joins
Prior art date
Application number
SV2010003728A
Other languages
English (en)
Inventor
Hans Dietrich Menssen
Joerg Pinkert
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of SV2010003728A publication Critical patent/SV2010003728A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USO DE UNA MOLÉCULA RADIOMARCADA QUE SE UNE ESPECÍFICAMENTE AL ED-B DE LA FIBRONECTINA EN UN MÉTODO DE TRATAMIENTO DE PACIENTES CON LINFOMA DE HODGKIN, EN PARTICULAR LINFOMA DE HODGKIN PRIMARIO REFRACTARIO O LINFOMA DE HODGKIN RECURRENTE DESPUÉS DE UNA QUIMIOTERAPIA, Y DE PACIENTES CON LINFOMA DE HODGKIN PROGRAMADOS PARA RECIBIR UNA TERAPIA DE MODALIDAD COMBINADA PRIMARIA
SV2010003728A 2008-05-08 2010-11-08 Uso de una molecula radiomarcada que se une especificamente a la ed-b de la fibronectina en un metodo para el linfoma de hodgkin SV2010003728A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5150008P 2008-05-08 2008-05-08
EP08075485A EP2116555A1 (en) 2008-05-08 2008-05-08 Use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of treatment of Hodgkin lymphoma

Publications (1)

Publication Number Publication Date
SV2010003728A true SV2010003728A (es) 2011-03-15

Family

ID=39760894

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2010003728A SV2010003728A (es) 2008-05-08 2010-11-08 Uso de una molecula radiomarcada que se une especificamente a la ed-b de la fibronectina en un metodo para el linfoma de hodgkin

Country Status (15)

Country Link
US (1) US20110123444A1 (es)
EP (2) EP2116555A1 (es)
JP (1) JP2011519883A (es)
KR (1) KR20110004867A (es)
CN (1) CN102015768A (es)
AU (1) AU2009243715A1 (es)
BR (1) BRPI0912200A2 (es)
CA (1) CA2723323A1 (es)
DO (1) DOP2010000336A (es)
EA (1) EA201001731A1 (es)
IL (1) IL208615A0 (es)
MA (1) MA32289B1 (es)
MX (1) MX2010012215A (es)
SV (1) SV2010003728A (es)
WO (1) WO2009135627A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009047243A1 (de) 2009-11-27 2011-06-01 Orgentec Diagnostika Gmbh Monospezifische Polypeptidreagenzien
US20180340936A1 (en) * 2015-11-16 2018-11-29 Hefei Lifeon Pharmaceutical Co. Ltd. Use of ed-b protein in diagnosis of tissue hyperplasia

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE3856559T2 (de) 1987-05-21 2004-04-29 Micromet Ag Multifunktionelle Proteine mit vorbestimmter Zielsetzung
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ATE241011T1 (de) 1991-02-27 2003-06-15 Micromet Ag Serin-reiche peptidlinker
DK1136556T3 (da) 1991-11-25 2005-10-03 Enzon Inc Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner
DE69232604T2 (de) 1992-11-04 2002-11-07 City Of Hope Duarte Antikörperkonstrukte
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
TWI259837B (en) 1998-05-11 2006-08-11 Eidgenossische Tech Hochscule Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
US8623373B2 (en) 2000-02-24 2014-01-07 Philogen S.P.A. Compositions and methods for treatment of angiogenesis in pathological lesions
RU2352582C2 (ru) 2002-01-03 2009-04-20 Шеринг Акциенгезельшафт Конъюгаты, содержащие антитело, специфическое для ed-в-домена фибронектина, и их применение для обнаружения и лечения опухолей
ES2337566T3 (es) * 2002-03-11 2010-04-27 Philogen S.P.A. Anticuerpos derivados de anti ed-b l19 y vasculatura tumoral objetivo.
CN101534865A (zh) * 2005-10-19 2009-09-16 Ibc药品公司 生物活性装配体的制备方法及其用途

Also Published As

Publication number Publication date
DOP2010000336A (es) 2010-12-15
KR20110004867A (ko) 2011-01-14
MX2010012215A (es) 2010-12-06
BRPI0912200A2 (pt) 2016-07-26
IL208615A0 (en) 2010-12-30
MA32289B1 (fr) 2011-05-02
EA201001731A1 (ru) 2011-06-30
EP2276779A1 (en) 2011-01-26
EP2116555A1 (en) 2009-11-11
CN102015768A (zh) 2011-04-13
JP2011519883A (ja) 2011-07-14
AU2009243715A1 (en) 2009-11-12
WO2009135627A1 (en) 2009-11-12
US20110123444A1 (en) 2011-05-26
CA2723323A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
CY1121065T1 (el) Αναστολεις ιβατ για την αγωγη ηπατικων νοσων
PE20121024A1 (es) Moleculas de union biespecificas para la terapia antigiogenesis
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1120413T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
CY1118530T1 (el) Glyx-13 για χρηση σε μεθοδο θεραπευτικης αγωγης ανθεκτικης σε θεραπεια καταθλιψης
BRPI0908503A2 (pt) partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos
CY1116261T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
FI20085839A0 (fi) Menetelmiä ja välineitä pehmytkudosteknologiaan
CR20110553A (es) Terapia complementaria contra el cáncer
ECSP10010527A (es) Terapia de combinacion con antagonistas de c-met y egfr
BRPI0906549A2 (pt) Bandagens médicas com válvulas e kits contendo as mesmas.
BRPI0914678A8 (pt) Dispositivo dispensador para vaso sanitário e processo para distribuir uma composição de tratamento a um dispositivo sanitário
SV2008002980A (es) Composiciones y metodos de uso para anticuerpos de dickkopf-1 y/0 -4
EA201001372A1 (ru) Формы рифаксимина и их применение
CL2012003656A1 (es) Uso de una composicion que comprende una enzima de reemplazo para la enzima lisosomal a una concentracion mayor a 5 mg/ml para tratar sintomas somaticos de la deficiencia de la enzima subyacente.
AR083717A1 (es) Mejoras en tecnicas de gofrado
CL2008000896A1 (es) Composicion que mantiene el cuidado bucal periodico que comprende un aminoacido basico; uso en el tratamiento terapeutico de la superficie bucal.
EA201100978A1 (ru) Схема приема агониста рецептора s1p
BR112012015428A2 (pt) composições de cuidado oral para uso com um dispositivo de luz oral
HN2009003038A (es) Anticuerpos contra la il-25
NI201200090A (es) Composiciones para tratar náusea y vómito centralmente mediados
CY1116216T1 (el) Μεθοδος θεραπειας ασθενειας αποθηκευσης γλυκογονου
GT200800068S (es) Carena para motocicleta
CO6351779A2 (es) Inhibidores de molecula pequeña de la activacion n-terminal del receptor de androgenos
EA201270345A1 (ru) Модифицированный фрагмент агрина, способный восстанавливать мышечную силу, для применения в качестве лекарства